Heparin API Market By Type (Heparin Calcium, Heparin Sodium and Other) and Application (Low Molecular Weight Heparin (LMWH) And Unfractionated Heparin (UFH)) - Global Industry Analysis And Forecast To 2025

Industry Outlook

The Heparin API Heparin is a drug that is used as an anticoagulant. Specifically it is utilized to treat and avert deep vein thrombosis, arterial thromboembolism, and pulmonary embolism. It is additionally used as a part of the treatment of heart attacks and unsteady angina. It is given by injection into a vein. Different uses incorporate kidney dialysis machines and inside test tubes. The most common side effects are bleeding, low blood platelets, and pain at the injection site. Major side effects incorporate heparin incited thrombocytopenia. Constant care is required in those with poor kidney function. Heparin is known to be generally safe for use amid pregnancy and breastfeeding.

Market Segmentation

The Heparin API Market is based on different segments namely, by type the market is segmented into heparin calcium, heparin sodium and other; by application the market is segmented into low molecular weight heparin (LMWH) and unfractionated heparin (UFH)


Heparin API Market By Type


Heparin Calcium
Heparin Sodium
Other


Heparin API Market By Application

Low Molecular Weight Heparin (LMWH)
Unfractionated Heparin (UFH)




Regional Insights

On a global front, the Heparin API Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). Germany accounted for the major share in the heparin market in Europe in 2015 and is anticipated to continue its dominance till over the forecast period.


Heparin API Market, By Region


North America



U.S.
Canada
Mexico

Europe


Germany
UK
France
Russia
Italy
Rest of Europe

Asia-Pacific


China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific

South America


Brazil
Argentina
Columbia
Rest of South America

Middle East and Africa


Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA


Competitive Analysis

The leading players in the market are Aspen Oss BV, Pfizer, Jiulong Biochemicals, Shenzhen Hepalink Pharmaceutical Co Ltd, Bioibérica, Sichuan Deebio Pharmaceutical Co LTD, Changzhou Qianhong, Yino Pharma Limited, Opocrin Spa, Tiandong County, Hebei Changshan Biochemical Pharmaceutical Co. Ltd, Yantai Dongcheng. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.


Aspen Oss BV
Pfizer
Jiulong Biochemicals
Shenzhen Hepalink Pharmaceutical Co Ltd
Bioibérica
Sichuan Deebio Pharmaceutical Co LTD
Changzhou Qianhong
Yino Pharma Limited
Opocrin Spa
Tiandong County
Hebei Changshan Biochemical Pharmaceutical Co. Ltd
Yantai Dongcheng


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?